Clinical Trials in Miami

Showing 5781-5800 of 8,701 trials

Sodium Management in Acute Neurological Injury

NCT01558843

This multicenter, observational, study will enroll severe neurologically injured patients both prospectively and retrospectively. The aims are to identify the percent of neurocritical care patients with sodium levels ≤ 135 mEq/L, describe treatment strategies employed, determine the correlation of clinical factors (i.e. GCS, ICP) with serum sodium concentrations in patients prior to sodium altering therapy, and evaluate outcomes through evaluation of length of stay, discharge disposition, and modified Rankin score (mRS).

This Study is to Understand the Current Practice of Sodium Management in Acute Neurological Injury

Washington University School of Medicine400 participantsStarted Feb 2012

Hartford, Connecticut, United States • New Haven, Connecticut, United States • Miami, Florida, United States +14 more locations

TERMINATEDPhase 3< 1 mile

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

NCT01975389

This study evaluates the PCSK9 inhibitor, Bococizumab (PF-04950615;RN316), compared to placebo, in reducing the occurrrence of major cardiovascular events, including cardiovascular death, myocardial infarction, stroke, and unstable angina requiring urgent revascularization in high risk subjects who are receiving background lipid lowering therapy and have cholesterol laboratory values of LDL-C \>/= 100 mg/dL (2.6 mmol/L) or non-HDL-C \>/=130 mg/dL (3.4 mmol/L).

Cardiovascular Disease

Pfizer10,564 participantsStarted Oct 2013

Athens, Alabama, United States • Athens, Alabama, United States • Birmingham, Alabama, United States +1592 more locations

Sodium Management in Acute Neurological Injury

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

Find Trials by Condition in Miami

MEmbranous Nephropathy Trial Of Rituximab

A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas

Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy

Epicardial Fat in Coronary Artery Disease

Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy

Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma

Long-Term Patient Satisfaction of Facial Aesthetic Treatment With BOTOX®

24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis

Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus

Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions

Study Evaluating Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB Study

Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations

Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis

Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema

A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion

Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema

Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)

Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children